Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Beone, Celltrion, Daiichi, Incyte, J&J, Memo, Novo, Sangamo.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Huxley Medical, Pearl.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott, Cutera, Enable Injections, Femasys, J&J.
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Adagene, Aldeyra, Astrazeneca, Chiesi, Daiichi, GSK, Organogenesis, Palvella, Sprout.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Celltivity, Clarius Mobile Health, CMR Surgial, Hyperfine, Medibeacon, Numares, Pathmaker Neurosystems, Rivanna Medical, Sleepres.
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Abpro, Algia, Amphastar, Anavex, Biocryst, Celltrion, Fibrogen, Fortress, Innoviva, Janssen, Lenz, Leo, LIB, Milestone, Moderna, Pilatus, Sanofi, Vanda.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: BD, Bluewind Medical, May Health, Medivis, MPM Medical, Roche, Zephyrus.
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Askbio, Innocare, Junshi, Sagimet, Stada Arzneimittel, Teva.
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Acadia, Amgen, Apellis, Bio-Thera, GSK, Immunitybio, Kymera, Merck, Novo Nordisk, Sobi, Stada.
RSS